- Home
- NXPI vs COR Comparison
NXPI vs COR Comparison
Compare NXPI & COR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NXPI | COR |
|---|---|---|
| Founded | 2006 | 2001 |
| Country | Netherlands | United States |
| Employees | N/A | N/A |
| Industry | Semiconductors | Other Pharmaceuticals |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 57.8B | 68.5B |
| IPO Year | 2007 | 2001 |
Fundamental Metrics
Financial Performance| Metric | NXPI | COR |
|---|---|---|
| Price | $217.52 | $370.61 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 18 | 13 |
| Target Price | $245.89 | ★ $395.23 |
| AVG Volume (30 Days) | ★ 2.7M | 1.2M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | ★ 1.88% | 0.65% |
| EPS Growth | N/A | ★ 5.71 |
| EPS | ★ 7.95 | 2.87 |
| Revenue | $12,269,000,000.00 | ★ $321,332,819,000.00 |
| Revenue This Year | $12.63 | $8.97 |
| Revenue Next Year | $10.40 | $6.76 |
| P/E Ratio | ★ $27.17 | $129.72 |
| Revenue Growth | N/A | ★ 9.31 |
| 52 Week Low | $148.09 | $248.59 |
| 52 Week High | $256.36 | $377.54 |
Technical Indicators
Market Signals| Indicator | NXPI | COR |
|---|---|---|
| Relative Strength Index (RSI) | 37.88 | 59.30 |
| Support Level | $205.31 | $331.73 |
| Resistance Level | $230.80 | $376.22 |
| Average True Range (ATR) | 8.01 | 8.48 |
| MACD | -2.41 | 0.79 |
| Stochastic Oscillator | 9.09 | 80.83 |
Price Performance
Historical ComparisonAbout NXPI NXP Semiconductors N.V.
NXP Semiconductors is a leading supplier of high-performance mixed-signal products. The firm acquired Freescale Semiconductor in 2015 and now has significant market share in the automotive market, where it supplies microcontrollers and analog chips into automotive clusters, powertrains, infotainment systems, and radars. NXP Semiconductors also serves industrial and Internet of Things, mobile, and communications infrastructure.
About COR Cencora Inc.
Cencora is one of three leading domestic pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health hold over 90% share of the US pharmaceutical wholesale industry. Cencora also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). Cencora expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe.